HCV-RNA titres through the course of treatment for 21 non-SVR patients analyzed for protease sequence variations.
收藏NIAID Data Ecosystem2026-03-09 收录
数据链接：
官方服务：
资源简介：
Sample analyzed for resistance is marked in bold. SVR; sustained viral response. TEL; telaprevir, BOC; boceprevir NT; Not taken. NA; Not available. GT; genotype. EOT; End of treatment. (12) week 12, (24) week 24, (29) week 29, (36) week 36. (48) week 48, (56) week 56. HCV-RNA titres through the course of treatment for 21 non-SVR patients analyzed for protease sequence variations.
创建时间：
2014-12-01
